• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用巨磁电阻生物传感器检测因子 Xa 活性。

Detection of factor Xa activity using giant magnetoresistive biosensors.

机构信息

Department of Mechanical and Biomedical Engineering, Ewha Womans University, Seoul, 03760, Republic of Korea; Graduate Program in Smart Factory, Ewha Womans University, Seoul, 03760, Republic of Korea.

Department of Neurology, Seoul Hospital, College of Medicine, Ewha Womans University, Seoul, 07804, Republic of Korea.

出版信息

Anal Chim Acta. 2024 Dec 1;1331:343347. doi: 10.1016/j.aca.2024.343347. Epub 2024 Oct 16.

DOI:10.1016/j.aca.2024.343347
PMID:39532428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11561370/
Abstract

BACKGROUND

As anticoagulants are widely used to treat patients with atrial fibrillation (AF) and other thrombotic conditions, it is necessary for physicians to determine whether the medication has been taken in emergencies. Among many anticoagulants, rivaroxaban has attracted attention due to its safety and convenience. Since rivaroxaban inhibits activated coagulation factor X (factor Xa), measuring factor Xa activity can determine the presence of rivaroxaban.

RESULTS

We report a magnetic biosensing platform capable of measuring the activity of factor Xa using peptide substrates conjugated with magnetic nanoparticles (MNPs). Due to the size of factor Xa, a new method of solution-phase assays was proposed for magnetic biosensing platforms to address issues with immobilized peptides on the sensors. This method was validated with factor Xa and trypsin, both of which are serine proteases. In the solution-phase assays, samples with either the enzymes of interest or no enzyme were simultaneously measured, and the activity of the enzyme was estimated using the difference between the measurements. Unlike conventional optical methods, our platform was capable of detecting the activity of factor Xa at 2 μg mL with a 30 min sample incubation.

SIGNIFICANCE

The assay using giant magnetoresistive biosensors outperformed conventional optical techniques. This platform can facilitate the determination of the presence of rivaroxaban and assist physicians in deciding on appropriate treatments for patients.

摘要

背景

由于抗凝剂被广泛用于治疗心房颤动(AF)和其他血栓性疾病的患者,医生有必要确定药物是否在紧急情况下服用。在许多抗凝剂中,利伐沙班因其安全性和便利性而引起关注。由于利伐沙班抑制激活的凝血因子 X(因子 Xa),因此测量因子 Xa 的活性可以确定利伐沙班的存在。

结果

我们报告了一种使用与磁性纳米颗粒(MNPs)偶联的肽底物来测量因子 Xa 活性的磁生物传感平台。由于因子 Xa 的大小,我们为磁性生物传感平台提出了一种新的溶液相测定方法,以解决传感器上固定化肽的问题。该方法使用因子 Xa 和胰蛋白酶进行了验证,这两种酶都是丝氨酸蛋白酶。在溶液相测定中,同时测量了含有感兴趣酶或无酶的样品,并使用测量值之间的差异来估计酶的活性。与传统的光学方法不同,我们的平台能够在 30 分钟的样品孵育时间内以 2μg/mL 的浓度检测因子 Xa 的活性。

意义

使用巨磁电阻生物传感器的测定方法优于传统的光学技术。该平台可以促进利伐沙班存在的确定,并帮助医生为患者决定适当的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/65ace3d09c7a/nihms-2031280-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/b626aff2cc36/nihms-2031280-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/c39775a8f319/nihms-2031280-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/3f8ca46e6fd6/nihms-2031280-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/81bace2daf2b/nihms-2031280-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/65ace3d09c7a/nihms-2031280-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/b626aff2cc36/nihms-2031280-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/c39775a8f319/nihms-2031280-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/3f8ca46e6fd6/nihms-2031280-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/81bace2daf2b/nihms-2031280-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7b/11561370/65ace3d09c7a/nihms-2031280-f0005.jpg

相似文献

1
Detection of factor Xa activity using giant magnetoresistive biosensors.使用巨磁电阻生物传感器检测因子 Xa 活性。
Anal Chim Acta. 2024 Dec 1;1331:343347. doi: 10.1016/j.aca.2024.343347. Epub 2024 Oct 16.
2
[Evaluation of oral anticoagulation with rivaroxaban, in patients with new onset non valvular atrial fibrillation].利伐沙班用于新诊断非瓣膜性心房颤动患者口服抗凝治疗的评估
Rev Med Chil. 2016 Sep;144(9):1103-1111. doi: 10.4067/S0034-98872016000900002.
3
Giant magnetoresistive biosensors for real-time quantitative detection of protease activity.用于实时定量检测蛋白酶活性的巨磁电阻生物传感器。
Sci Rep. 2020 May 14;10(1):7941. doi: 10.1038/s41598-020-62910-2.
4
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment Values.Andexanet Alfa 逆转因子 Xa 抑制剂可能会增加血栓形成的风险,与治疗前相比。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619863493. doi: 10.1177/1076029619863493.
5
Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.利伐沙班在谷浓度稳态时对因子 Xa 的抑制作用可显著降低凝血酶生成。
Br J Clin Pharmacol. 2018 Jan;84(1):79-87. doi: 10.1111/bcp.13429. Epub 2017 Oct 18.
6
A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa.从印度锯鳞蝰毒液中纯化出的一种新肽(芦维普酶)通过对凝血酶和Xa因子的非酶抑制作用显示出强大的抗凝活性。
Biochimie. 2014 Oct;105:149-58. doi: 10.1016/j.biochi.2014.07.006. Epub 2014 Jul 17.
7
Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity.利伐沙班和阿哌沙班诱导凝血因子 Xa 的纤维蛋白溶解活性。
J Thromb Haemost. 2018 Nov;16(11):2276-2288. doi: 10.1111/jth.14281. Epub 2018 Oct 9.
8
Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.抗 Xa 活性测定用于检测利伐沙班血浆浓度的准确性和一致性。
J Thromb Haemost. 2017 Aug;15(8):1576-1583. doi: 10.1111/jth.13747. Epub 2017 Jul 17.
9
Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.新型基于邻氨基苯甲酰胺的凝血因子Xa抑制剂:药物设计、合成及生物学评价
Molecules. 2016 Apr 14;21(4):491. doi: 10.3390/molecules21040491.
10
Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.最小修饰的人凝血因子 X 以绕过直接因子 Xa 抑制剂。
J Thromb Haemost. 2024 Aug;22(8):2211-2226. doi: 10.1016/j.jtha.2024.04.022. Epub 2024 May 9.

引用本文的文献

1
Denaturation methods for reusable magnetic biosensors.可重复使用的磁生物传感器的变性方法。
Lab Chip. 2025 May 29. doi: 10.1039/d5lc00040h.

本文引用的文献

1
A GMR enzymatic assay for quantifying nuclease and peptidase activity.一种用于定量核酸酶和肽酶活性的GMR酶法测定。
Front Bioeng Biotechnol. 2024 Mar 13;12:1363186. doi: 10.3389/fbioe.2024.1363186. eCollection 2024.
2
Evaluation of restriction and Cas endonuclease kinetics using matrix-insensitive magnetic biosensors.使用基质不敏感的磁生物传感器评估限制和 Cas 内切酶的动力学。
Biosens Bioelectron. 2024 Apr 1;249:116017. doi: 10.1016/j.bios.2024.116017. Epub 2024 Jan 9.
3
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis.近期直接口服抗凝药物使用患者的急性缺血性脑卒中的静脉溶栓治疗:系统评价和荟萃分析。
J Am Heart Assoc. 2023 Dec 19;12(24):e031669. doi: 10.1161/JAHA.123.031669. Epub 2023 Dec 18.
4
Real-time temperature correction for magnetoresistive biosensors integrated with temperature modulator.集成温度调制器的磁阻生物传感器的实时温度校正
Biosens Bioelectron X. 2023 Sep;14. doi: 10.1016/j.biosx.2023.100356. Epub 2023 Apr 25.
5
Magnetic supercluster particles for highly sensitive magnetic biosensing of proteins.用于高度敏感的蛋白质磁生物传感的磁性超顺磁颗粒。
Mikrochim Acta. 2022 Jun 14;189(7):256. doi: 10.1007/s00604-022-05354-x.
6
Giant magnetoresistive biosensors for real-time quantitative detection of protease activity.用于实时定量检测蛋白酶活性的巨磁电阻生物传感器。
Sci Rep. 2020 May 14;10(1):7941. doi: 10.1038/s41598-020-62910-2.
7
A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting.一种用于在急诊室环境中检测直接口服抗凝剂(利伐沙班和阿哌沙班)的新测试。
Crit Care Explor. 2019 Aug 20;1(8):e0024. doi: 10.1097/CCE.0000000000000024. eCollection 2019 Aug.
8
Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report.利伐沙班抗凝治疗的急性缺血性卒中患者的溶栓治疗:一例报告。
Medicine (Baltimore). 2019 Feb;98(8):e14560. doi: 10.1097/MD.0000000000014560.
9
Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.直接口服抗凝药对房颤患者口服抗凝治疗率的影响。
J Am Coll Cardiol. 2017 May 23;69(20):2475-2484. doi: 10.1016/j.jacc.2017.03.540.
10
Magneto-nanosensor platform for probing low-affinity protein-protein interactions and identification of a low-affinity PD-L1/PD-L2 interaction.用于探测低亲和力蛋白-蛋白相互作用的磁纳米传感器平台,并鉴定出低亲和力 PD-L1/PD-L2 相互作用。
Nat Commun. 2016 Jul 22;7:12220. doi: 10.1038/ncomms12220.